disseminated intravascular coagulopathy - Nursing Case Study

Pathophysiology

• Primary mechanism: In disseminated intravascular coagulopathy (DIC), there is widespread activation of the coagulation cascade, often triggered by an underlying condition such as sepsis, trauma, or malignancy. This leads to excessive thrombin production and fibrin deposition in small blood vessels.

• Secondary mechanism: The overactive clotting consumes platelets and coagulation factors, causing thrombocytopenia and coagulopathy. Simultaneously, fibrinolytic pathways are activated, resulting in increased breakdown of clots and further depletion of clotting components.

• Key complication: This imbalance between clot formation and breakdown leads to both thrombosis and bleeding. Patients may experience microvascular thrombi causing organ dysfunction and bleeding due to the depletion of clotting factors and platelets.

Patient Profile

Demographics:

45-year-old female, nurse

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Recent bacterial sepsis

• Current medications: Lisinopril, Metformin, Insulin, Prophylactic low-dose aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased bruising and bleeding

• Key symptoms: Petechiae, bleeding gums, fatigue, shortness of breath

• Vital signs: Temperature 38.5°C, Heart rate 110 bpm, Blood pressure 90/60 mmHg, Respiratory rate 22 breaths per minute, Oxygen saturation 94% on room air

Section 1

During the initial assessment, the attending physician and nursing team noted that the patient's condition was deteriorating. Her vital signs indicated a concerning trend: a further drop in blood pressure to 85/55 mmHg and an increase in heart rate to 120 bpm, suggesting potential hypovolemic shock due to bleeding. On physical examination, the petechiae had spread, and ecchymosis was evident on her extremities, indicative of worsening coagulopathy. Auscultation revealed crackles in the lower lung fields, raising concerns about pulmonary involvement, possibly secondary to microvascular thrombi or fluid overload. Her abdomen was soft, but there was mild tenderness in the right upper quadrant, warranting further investigation for potential hepatic involvement.

Lab results showed a significant decrease in platelet count to 30,000/µL, elevated D-dimer levels exceeding 5,000 ng/mL, and a prolonged prothrombin time (PT) of 22 seconds. Fibrinogen levels had dropped to 100 mg/dL, reinforcing the diagnosis of DIC. The elevated D-dimer and low fibrinogen suggested ongoing clot breakdown and depletion of clotting components. Arterial blood gas analysis revealed metabolic acidosis with a pH of 7.30 and a bicarbonate level of 18 mEq/L, likely due to lactic acidosis from tissue hypoperfusion. This constellation of findings necessitated immediate intervention to address both bleeding and potential thrombotic complications.

The clinical team initiated a multi-pronged intervention strategy, including the administration of fresh frozen plasma and platelet transfusions to replenish depleted clotting factors, alongside careful monitoring of fluid status to prevent fluid overload and support blood pressure. Despite these efforts, the patient developed new-onset confusion and lethargy, indicative of possible cerebral involvement. This change necessitated further imaging and neurological assessment to evaluate for potential intracranial bleeding or ischemic events, highlighting the complexity and progression of her condition. The team also adjusted her insulin regimen to maintain tighter glycemic control, recognizing the impact of hyperglycemia on worsening her coagulopathy and overall prognosis.

Section 2

New diagnostic results revealed further complications in the patient's condition. A CT scan of the head was performed to investigate her new-onset confusion and lethargy, which showed evidence of small ischemic strokes. These findings suggested that microvascular thrombi were also affecting the cerebral circulation, a known complication of disseminated intravascular coagulopathy (DIC). This necessitated a delicate balance in managing her coagulation status to prevent further thrombotic events while addressing ongoing bleeding risks.

Additionally, an abdominal ultrasound was conducted to explore the right upper quadrant tenderness. The ultrasound revealed mild hepatomegaly and a heterogeneous liver texture, suggestive of hepatic congestion or early signs of ischemic hepatitis, possibly due to compromised blood supply. Liver function tests showed elevated liver enzymes, with AST at 150 U/L and ALT at 135 U/L, indicating hepatic stress. These results underscored the multi-organ impact of DIC and prompted the clinical team to consider the risk of liver dysfunction in their ongoing management strategy.

These findings prompted a reassessment of the patient's management plan. The team decided to continue supportive care with transfusions but initiated low-dose heparin therapy cautiously to mitigate further thrombotic events, weighing the risks of exacerbating bleeding. The patient's fluid status was closely monitored, with adjustments made to prevent additional pulmonary congestion while ensuring adequate tissue perfusion. The integration of these diagnostic insights challenged the clinical team to refine their approach continually, emphasizing the need for vigilant monitoring and timely interventions in managing this complex and evolving condition.

Section 3

As the clinical team continued to manage the complex picture of disseminated intravascular coagulopathy (DIC) in this patient, new complications emerged, necessitating further adjustment of their therapeutic approach. Over the next 48 hours, the patient's condition began to show subtle signs of deterioration. Vital signs indicated a drop in blood pressure to 88/56 mmHg, accompanied by an increased heart rate of 112 beats per minute. These changes suggested a possible progression towards shock, likely exacerbated by ongoing bleeding and compromised organ perfusion due to microvascular thrombi.

Laboratory evaluations revealed a further decline in hemoglobin levels to 8.2 g/dL, with a persistently low platelet count of 45,000/µL. Coagulation profiles showed an increase in D-dimer to over 5,000 ng/mL, reflecting the intensifying consumptive coagulopathy. Additionally, a significant rise in lactate levels to 3.8 mmol/L indicated worsening tissue hypoperfusion and oxygenation. The patient's mental status fluctuated, with periods of increased confusion and lethargy, raising concerns about cerebral perfusion and the possibility of new or progressing ischemic events.

Given these developments, the clinical team recognized the need to reassess the current management strategy. They increased the intensity of supportive care, including more frequent blood product transfusions to address the bleeding risks and maintain hemodynamic stability. The low-dose heparin therapy was carefully titrated, with frequent monitoring of coagulation parameters to balance the dual risks of thrombosis and hemorrhage. Close monitoring of fluid balance continued, with adjustments made to optimize cardiac output and prevent further organ congestion. This evolving scenario underscored the critical importance of dynamic clinical reasoning and adaptive management in navigating the challenges of DIC, setting the stage for further exploration of the patient's response to these intensified interventions.

Section 4

As the clinical team continued to navigate the complexities of disseminated intravascular coagulopathy (DIC), a new complication emerged, demanding immediate attention and further adjustment of their therapeutic strategy. Within the following 24 hours, the patient's respiratory status began to deteriorate. Initial assessment findings revealed increasing respiratory distress, characterized by tachypnea with a respiratory rate climbing to 28 breaths per minute and labored breathing. Auscultation of the lungs revealed bilateral crackles, suggesting the possibility of acute pulmonary edema or the development of acute respiratory distress syndrome (ARDS), likely secondary to systemic inflammation and capillary leak syndrome associated with the ongoing DIC.

Concurrent with these respiratory changes, arterial blood gas analysis showed a concerning decline in partial pressure of oxygen (PaO2) to 60 mmHg and an increase in partial pressure of carbon dioxide (PaCO2) to 48 mmHg, indicative of impending respiratory failure. The patient's oxygen saturation on room air dropped to 89%, necessitating the initiation of supplemental oxygen therapy. The intensification of the coagulopathy was further corroborated by a fibrinogen level that had decreased to 120 mg/dL, suggesting that the consumptive process was depleting essential clotting factors at an accelerated rate.

The team recognized these new developments as a critical turning point in the patient's care trajectory. In response, they prioritized interventions aimed at stabilizing the respiratory function while continuing to manage the underlying coagulopathy. Non-invasive ventilation was considered to support breathing efforts and improve oxygenation, while cautious administration of diuretics was initiated to manage potential fluid overload contributing to pulmonary edema. The team also deliberated the need for potential escalation to mechanical ventilation should the patient's respiratory status fail to improve. This scenario highlighted the necessity of dynamic and integrative clinical reasoning, as the team worked to balance the multifaceted demands of DIC management with the acute need to address new and evolving complications, setting the stage for ongoing monitoring and adaptation in the patient's treatment plan.

Section 5

As the clinical team continued their vigilant monitoring of the patient, a new complication emerged within the next 12 hours. The patient's renal function began to decline, a common occurrence in severe cases of DIC due to microvascular thrombosis and potential acute tubular necrosis. This was evidenced by a rising serum creatinine level, which had increased from 1.2 mg/dL to 2.5 mg/dL, and a significant reduction in urine output to less than 20 mL/hour over a 6-hour period, pointing towards acute kidney injury (AKI). The team immediately recognized the critical importance of this development, as it posed additional challenges in fluid management and medication dosing.

In response to these renal complications, the clinical team adjusted their therapeutic strategy. They initiated a renal-protective regimen, which included closely monitoring fluid balance to avoid exacerbating pulmonary edema while ensuring adequate perfusion to the kidneys. The nephrology team was consulted to evaluate the potential need for renal replacement therapy if the patient's condition continued to deteriorate. Furthermore, the team reassessed all medications, particularly those potentially nephrotoxic, to minimize any additional renal burden.

Concurrently, the team remained focused on the patient's respiratory status and overall hemodynamic stability. The non-invasive ventilation had shown some improvement in oxygenation, but the patient's oxygen saturation remained tenuous, fluctuating between 90-92% with supplemental oxygen. Ongoing assessment of the patient's vital signs revealed a blood pressure of 98/65 mmHg, heart rate of 115 beats per minute, and continued tachypnea, necessitating close observation for any signs of further decompensation. This comprehensive approach underscored the team's commitment to integrative clinical reasoning, as they balanced the intricacies of managing DIC with the new renal and respiratory challenges, setting the stage for further adjustments in the patient's evolving care plan.